Phase II Trial of Atezolizumab Combined With Carboplatin and Pemetrexed for Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer With Untreated Brain Metastases (Atezo-Brain, GECP17/05)

PURPOSE: The Atezo-Brain study evaluated atezolizumab combined with chemotherapy in patients with advanced non–small-cell lung cancer (NSCLC) with untreated brain metastases, a population traditionally excluded from trials. METHODS: This single-arm phase II clinical trial enrolled patients with adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadal, Ernest, Rodríguez-Abreu, Delvys, Simó, Marta, Massutí, Bartomeu, Juan, Oscar, Huidobro, Gerardo, López, Rafael, De Castro, Javier, Estival, Anna, Mosquera, Joaquín, Sullivan, Ivana, Felip, Enriqueta, Blasco, Ana, Guirado, Maria, Pereira, Eva, Vilariño, Noelia, Navarro, Valentín, Bruna, Jordi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553096/
https://www.ncbi.nlm.nih.gov/pubmed/37603816
http://dx.doi.org/10.1200/JCO.22.02561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553096/
https://www.ncbi.nlm.nih.gov/pubmed/37603816
http://dx.doi.org/10.1200/JCO.22.02561

Ejemplares similares